공공성 유형의 시대적 탐색에 관한 연구: 대통령 연설문 내용분석을 중심으로

노은경(盧垠庚),이영규(李?揆),홍성우(洪性佑) 한국공공관리학회 2019 한국공공관리학보 Vol.33 No.3

본 연구는 정부 수립 이후 각 정권별 대통령의 연설문 분석을 통해 공공성의 개념과 유형은 어떻게 나타나고, 또한 어떻게 변화되어 왔는지를 탐색해 보는데 목적을 두었다. 이를 위해 전직 대통령 아홉명의 19개 연설문을 대상으로 의미 연결망 분석을 시행하였다. 먼저 전체 대통령 연설문과 개별 대통령 연설문의 단어에 대한 빈도분석을 실시하고, 이후 각 대통령별로 중심성 분석과 CONCOR분석을 수행하여 연설문을 통해 대통령별로 강조하였던 공공성의 유형과 특성을 도출해 보았다. 분석결과, 공공성의 유형은 정치적 공공성과 제도적 공공성에 비해 경제적 공공성과 사회적 공공성이 강조되는 경향을 보였으며, 특히 경제적 공공성과 사회적 공공성이 반복적으로 강조되는 규칙성도 확인할 수도 있었다. 김대중 대통령과 이명박 대통령의 연설문에서 외교 분야의 단어가 집중되었지만 김대중정권의 외교중심 단어는 남북 평화를 통해 사회 안정에 집중했다는 점과 이명박 정권은 경제 발전 추구에 의한 외교 중심 단어가 관찰되었다는 것이 차이점으로 나타났다. 또한, 노무현 대통령이 제도적 개선으로 투명성과 책임 있는 정부 모색과 지방분권 및 균형발전을 시도했다는 점에서 제도적 공공성 유형이 확인되었다는 점도 특징으로 제시할 수 있다.

A case of mediastinal ectopic thyroid presenting with a paratracheal mass

노은,홍은실,안화영,박소연,윤호일,박경수,박영주 대한내과학회 2013 The Korean Journal of Internal Medicine Vol.28 No.3

Mediastinal ectopic thyroid is a very rare condition, with few reported cases in the literature and no reported cases in Korea. This report describes an asymptomatic 65-year-old man with a right paratracheal mass compressing the superior vena. Additionally, the epidemiology, clinical manifestation, diagnosis, and management of mediastinal ectopic thyroids are discussed. A mediastinal ectopic thyroid should be considered in the differential diagnosis of all mediastinal masses. Surgical excision is recommended for both the diagnosis and treatment of this condition, because of its potential for malignancy and compression of mediastinal structures. This case demonstrates the clinical importance of mediastinal etopic thyroid.

Combining Ezetimibe and Rosuvastatin: Impacts on Insulin Sensitivity and Vascular Inflammation in Patients with Type 2 Diabetes Mellitus

노은 대한당뇨병학회 2024 Diabetes and Metabolism Journal Vol.48 No.1

Editorial

The Role of Adipose Tissue Lipolysis in Diet-Induced Obesity: Focus on Vimentin

노은,류혜진 대한당뇨병학회 2021 Diabetes and Metabolism Journal Vol.45 No.1

Editorial

Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism

노은,송도경,김민선 생화학분자생물학회 2016 Experimental and molecular medicine Vol.48 No.-

Accumulated evidence from genetic animal models suggests that the brain, particularly the hypothalamus, has a key role in the homeostatic regulation of energy and glucose metabolism. The brain integrates multiple metabolic inputs from the periphery through nutrients, gut-derived satiety signals and adiposity-related hormones. The brain modulates various aspects of metabolism, such as food intake, energy expenditure, insulin secretion, hepatic glucose production and glucose/fatty acid metabolism in adipose tissue and skeletal muscle. Highly coordinated interactions between the brain and peripheral metabolic organs are critical for the maintenance of energy and glucose homeostasis. Defective crosstalk between the brain and peripheral organs contributes to the development of obesity and type 2 diabetes. Here we comprehensively review the above topics, discussing the main findings related to the role of the brain in the homeostatic regulation of energy and glucose metabolism.

Age- and Sex-Related Differential Associations between Body Composition and Diabetes Mellitus

노은,황순영,김정아,이유빈,홍소현,김남훈,서지아,김신곤,김난희,최경묵,백세현,류혜진 대한당뇨병학회 2021 Diabetes and Metabolism Journal Vol.45 No.2

Background: The age- and sex-related differences on the impacts of body composition on diabetes mellitus (DM) remain uncertain. Methods: The fourth and fifth Korea National Health and Nutrition Examination Survey included 15,586 subjects over 30 years of age who completed dual-energy X-ray absorptiometry. We conducted a cross-sectional study to investigate whether muscle mass index (MMI), defined as appendicular skeletal muscle divided by body mass index (BMI), and fat mass index (FMI), defined as trunk fat mass divided by BMI, were differently associated with DM according to age and sex. Results: In multivariate logistic regression, the risk for DM significantly increased across quartiles of FMI in men aged ≥70. Meanwhile, MMI showed a protective association with DM in men of the same age. The odds ratios (ORs) for the highest quartile versus the lowest quartile of FMI and MMI were 3.116 (95% confidence interval [CI], 1.405 to 6.914) and 0.295 (95% CI, 0.157 to 0.554), respectively. In women, the ORs of DM was significantly different across FMI quartiles in those over age 50. The highest quartile of FMI exhibited increased ORs of DM in subjects aged 50 to 69 (OR, 1.891; 95% CI, 1.229 to 2.908) and ≥70 (OR, 2.275; 95% CI, 1.103 to 4.69) compared to lowest quartile. However, MMI was not significantly associated with DM in women of all age groups. Conclusion: Both FMI and MMI were independent risk factors for DM in men aged 70 years or more. In women over 50 years, FMI was independently associated with DM. There was no significant association between MMI and DM in women.

Prevalence and Management of Dyslipidemia in Korea:Korea National Health and Nutrition Examination Survey during 1998 to 2010

노은,고승현,권혁상,김난희,김재현,김철식,송기호,원종철,김대중,최성희,임수,차봉연 대한당뇨병학회 2013 Diabetes and Metabolism Journal Vol.37 No.6

Background: Dyslipidemia is a major risk factor of cardiovascular disease. The aim of this study was to investigate the changing trends in the prevalence and management status of dyslipidemia among Korean adults. Methods: The prevalence of dyslipidemia and the rates of awareness, treatment, and control of dyslipidemia were investigated in adults aged ≥20 years from the Korea National Health and Nutrition Surveys (KNHANES) 1998 to 2010. The updated National Cholesterol Education Program criteria was used, which define dyslipidemia as having one or more of the following lipid abnormalities:hypercholesterolemia (total cholesterol ≥240 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), hypertriglyceridemia (≥150 mg/dL), hyper-low density lipoprotein (LDL) cholesterolemia (≥160 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), and hypo-high density lipoprotein (HDL)-cholesterolemia (<40 mg/dL in men and <50 mg/dL in women). Results: The number of participants was 6,921, 4,894, 5,312, 2,733, 6,295, 6,900, and 5,738 in KNHANES 1998, 2001, 2005, 2007,2008, 2009, and 2010, respectively. Age-standardized prevalence rates of dyslipidemia were 54.0%, 65.8%, 66.5%, 60.6%, 58.7%,58.9%, and 59.0% in 1998, 2001, 2005, 2007, 2008, 2009, and 2010, respectively. Hypertriglyceridemia and hypo-HDL-cholesterolemia were the two most frequent lipid abnormalities. The overall prevalence of hypercholesterolemia and hyper-LDL-cholesterolemia increased by 1.36- and 1.35-fold in 2010 compared with 2007, respectively. Awareness, treatment, and control rates of dyslipidemia improved over the period of surveys in both sexes. In 2010, about 30% of dyslipidemic patients who received lipidlowering treatment reached target levels. Conclusion: Although the management status of dyslipidemia has improved during recent years, effective strategy is required for achieving better prevention, treatment, and control of dyslipidemia.

신약 중심의 비만 약물요법

노은,김민선 대한의사협회 2015 대한의사협회지 Vol.58 No.5

Obesity has become a global public health problem. The importance of obesity is highlighted by the fact that obesity-related comorbidities, such as type 2 diabetes, cardiovascular disease, and cancer, are a leading cause of death in Westernized countries. As endorsement of lifestyle modifications has proven to be inadequate to combat obesity, pharmacological treatment has become more critical for weight reduction as well as for the treatment of obesity-related morbidity and mortality. However, safety issues dampened the success of the development of antiobesity drugs, leaving orlistat as the single approved drug for long-term weight management until 2012, when two new anti-obesity drugs were approved by the FDA: lorcaserin and phentermine/topiramate. In 2014, another two drugs were approved by the US FDA for the treatment of obesity: naltrexone/bupropion and liraglutide. In this review, we describe the new FDA-approved anti-obesity drugs and briefly introduce other anti-obesity drugs still under development. (Word count: 144)

[‘새터민’이 ‘ 합터민’이 되는 날 꿈꾸는 노은지 님] 우리는 ‘합터민’입니다

노은지 샘터사 2011 월간 샘터 Vol.498 No.-

정신분열병 환자의 자기효능과 삶의 질에 관한 연구

노은선,권혜진,류은정 한국간호과학회 2001 Journal of Korean Academy of Nursing Vol.5 No.1

The purpose of this study is to identify the correlation that exists between quality of life and self-efficacy of schizophrenic patients, focusing on the influence of related factors on these varables. Method: The subjects of this study were 151 schizophrenic patients. The data were collected using questionnaires. The instruments used for this study were the general self-efficacy scale developed by Sherer & Maddex(1982), the specific self-efficacy scale modified and complemented by these co-researchers on the basis of the past studies and modified SIP by Voruganti(1996). The period of data collection was from July. 2000 to Jan. 2001. Data analysis was done by SPSS, t-test, ANOVA and the Pearson Correlation Coefficient. Result: 1. The level of self-efficacy showed a mean score of 60.0 and the level of quality of life, a mean score of 47.0. 2. The general characteristics affecting the self-efficacy of schizophrenic patients were staying with family (p=0.05) and employment (p=0.00). 3. The general characteristics affecting the quality of life of schizophrenic patients were staying with family (p=0.04), employment (p=0.05) and duration of illness (0.03). 4. A positive correlation was identified between self-efficacy and quality of life (r=-0.469, p=0.000). Conclusion: The study suggests that nursing intervention strategy should be worked out to develop a psychiatric rehabilitation program that can promote self-efficacy and thus enhance the quality of life of schizophrenic patients.